「Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma : A Reappraisal of 23 Japanese Patients Based on EBV Association and PD-L1 Expression in Tumor Cells」の関連論文
-
Expression of programmed cell death ligand-1 by immune cells in the microenvironment is a favorable prognostic factor for primary diffuse large B-cell lymphoma of the central nervous system
-
“その他の医原性免疫不全関連リンパ増殖性疾患”の臨床的特徴及び遺伝子変異解析についての研究
-
膵癌における腫瘍浸潤リンパ球と患者の生存に関連した三次リンパ組織の統合分析
-
悪性リンパ腫における血中循環細胞外遊離DNAを用いたゲノム解析に関する研究
-
胃・食道神経内分泌癌における治療標的分子発現の検討
-
Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression
-
Epstein-Barr Virus関連腫瘍におけるウイルス遺伝子発現と免疫回避・発癌機構の解明
-
Role of PD-L1 expression during the progression of submucosal gastric cancer
-
ニボルマブによる治療を行った転移性腎細胞癌患者における血清中可溶性PD-L1の予後予測効果
-
非小細胞肺癌におけるB7-1およびPD-1/PD-L1免疫チェックポイント分子の発現と転移巣での変化
-
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
-
Analysis of radiotherapy-induced alterations of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
癌幹細胞マーカーが、食道扁平上皮癌における術前化学療法の抵抗性を予測する
-
The Prognostic Significance of Peritumoral Lymphocytes’ Band-like Structure in Type II Endometrial Cancer
-
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma
-
PD-L1に対するsiRNAを封入したHVJ-Eはマウスグリオーマにおいて免疫抑制性の環境を改善し抗腫瘍効果を惹起する
-
Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study
-
Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma
-
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
-
肺腺癌におけるOvarian cancer immuno-reactive antigen domain containing 2 (OCIAD2) 発現の臨床病理学的意義および機能解析
-
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer
-
免疫組織化学検査を用いて子宮体癌の予後因子を再検討する
-
Prognostic role of the innate immune signature CD163 and
-
Study on the clinical outcome and molecular changes of precursor-targeted immune-mediated anemia treated with splenectomy [an abstract of entire text]
-
末梢血のmulticolor flowcytometryとliquid biopsyによるcell-free DNAのRHOAG17V変異解析を組み合わせた血管免疫芽球性T細胞リンパ腫解析法の確立 および ホジキンリンパ腫細胞株(AM-HLH)の樹立
-
Prognostic role of the innate immune signature CD163 and
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
癌患者ゲノミクスデータ解析を基盤とした乳癌幹細胞性維持機構の解明
-
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
-
婦人科悪性腫瘍担癌患者におけるインターロイキン17産生性T細胞の変動と抗腫瘍薬がPD-L1を含む免疫関連因子に与える影響、及びPD-L1とインターロイキン17産生誘導因子との関連性についての検討
-
Epidemiology of Japanese patients with atypical hemolytic uremic syndrome, and characteristics of patients with anti-CFH antibodies
-
シングルセルトランスクリプトーム解析を用いた食道扁平上皮癌内の腫瘍浸潤Bリンパ球における化学療法後の機能変化の解明
-
Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
-
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors
-
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
-
GATA6とCK5の免疫組織化学的発現表現型が術前化学療法後切除膵癌の予後を層別化する
-
口腔扁平上皮癌における腫瘍浸潤T細胞の免疫プロファイル解析
-
The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases
-
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
-
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue
-
Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
皮膚原発神経内分泌腫瘍におけるRB1遺伝子のターゲットシーケンスを含む臨床病理学的検討
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C : Results from LC-SCRUM-Asia study
-
再発難治性白血病に対する個別化医療を目指した患者特異的治療標的の同定
-
頭頸部扁平上皮癌における遺伝子変異と蛋白表現型によるp53機能分類
-
Runx3の下流遺伝子群の解析による悪性黒色腫に対する新規治療標的の創出